3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Endocrine
1
Conditions
Glioblastoma
393
Brain Neoplasms
162
Glioma
156
Gliosarcoma
130
Astrocytoma
111
Central Nervous System Neoplasms
109
Melanoma
75
Oligodendroglioma
73
Neuroblastoma
44
Neoplasms
33
Medulloblastoma
33
Neoplasm Metastasis
29
Recurrence
28
Ependymoma
25
Sarcoma
23
Sarcoma, Ewing
22
Rhabdomyosarcoma
18
Small Cell Lung Carcinoma
16
Lymphoma
16
Carcinoma, Non-Small-Cell Lung
16
Diffuse Intrinsic Pontine Glioma
15
Lung Neoplasms
14
Breast Neoplasms
14
Ovarian Neoplasms
13
Neuroendocrine Tumors
13
Choroid Plexus Neoplasms
13
Optic Nerve Glioma
11
Neuroectodermal Tumors, Primitive
11
Spinal Cord Neoplasms
10
Rhabdoid Tumor
10
Interventions
Geriatric Assessment
10
epigallocatechin gallate
2
Preoperative Exercise
2
Nutritional Support
2
Nutrition Assessment
2
Exercise
2
Ascorbic Acid
2
peflavit
1
microcrystalline cellulose
1
fisetin
1
diacetamate
1
cabozantinib
1
Tretinoin
1
Therapeutics
1
Temozolomide
1
Standard of Care
1
Restraint, Physical
1
Resistance Training
1
Quercetin
1
Qigong
1
Psychosocial Intervention
1
Protons
1
Photons
1
Methods
1
Immunonutrition Diet
1
Flavonoids
1
Enhanced Recovery After Surgery
1
Dasatinib
1
Control Groups
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Frailty
×
Temozolomide
×
Clear all
NCT05554003
2024-11-18
MeTe
European Institute of Oncology
Phase 2
Recruiting
46 enrolled